Tg Therapeutics (TGTX) Profit After Tax (2011 - 2026)
Tg Therapeutics (TGTX) recorded quarterly Profit After Tax of $19.8 million in Q1 2026, down 14.15% quarter-over-quarter from $23.0 million in Q4 2025, and up 290.85% on a YoY basis from $5.1 million in Q1 2025.
Tg Therapeutics (TGTX) Profit After Tax (2011 - 2026) Analysis & Trends
Tg Therapeutics' Profit After Tax history runs 16 years deep, the most recent figure standing at $19.8 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 290.85% year-over-year to $19.8 million; the TTM figure through Mar 2026 stood at $461.9 million (up 1079.81% YoY), while the FY2025 annual figure was $447.2 million, up 1812.41% from the prior year.
- Profit After Tax was $19.8 million for Q1 2026 at Tg Therapeutics, down from $23.0 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $390.9 million in Q3 2025 to a low of -$78.5 million in Q4 2022.
- Historically, Profit After Tax has averaged $16.4 million across 5 years, with a median of $3.9 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax sank 96.59% in 2024, then soared 9974.61% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$78.5 million in 2022, then surged by 81.63% to -$14.4 million in 2023, then soared by 261.84% to $23.3 million in 2024, then retreated by 1.26% to $23.0 million in 2025, then dropped by 14.15% to $19.8 million in 2026.
- The last three Profit After Tax figures came in at $19.8 million (Q1 2026), $23.0 million (Q4 2025), and $390.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Tg Therapeutics | 7.71 Bn | 7.06 Bn | 171.41 Mn | 19.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.78 Mn |
| Dec 31, 2025 | 23.04 Mn |
| Sep 30, 2025 | 390.90 Mn |
| Jun 30, 2025 | 28.19 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Dec 31, 2024 | 23.33 Mn |
| Sep 30, 2024 | 3.88 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | -10.71 Mn |
| Dec 31, 2023 | -14.42 Mn |
| Sep 30, 2023 | 113.93 Mn |
| Jun 30, 2023 | -47.61 Mn |
| Mar 31, 2023 | -39.23 Mn |
| Dec 31, 2022 | -78.47 Mn |
| Sep 30, 2022 | -35.82 Mn |
| Jun 30, 2022 | -40.51 Mn |
| Mar 31, 2022 | -69.01 Mn |
| Dec 31, 2021 | -93.34 Mn |
| Sep 30, 2021 | -85.64 Mn |
| Jun 30, 2021 | -78.50 Mn |